Table 3.

Comparison of baseline/outcome parameters at threshold value of HOMA-IR

SI. No.	Parameters		HOMA-IR <1.61 (n = 66)	HOMA-IR ≥ 1.61 (n = 16)	p value
1.	Age (years)		39.45 ± 14.43	38.50 ± 14.91	0.819
2.	Sex (males)		37 (56.0%)	9 (56.2%)	0.836
3.	Weight (kg)		57.76 ± 12.14	62.81 ± 13.84	0.194
4.	APACHE II		17.79 ± 6.39	18.25 ± 5.58	0.792
5.	SOFA score		8.3 ± 3.06	8.75 ± 2.95	0.595
6.	FIL (mU/L)		2.17 ± 1.36	7.42 ± 4.16	<0.001
7.	FBG (mg/dL)		134.33 ± 50.60	160.25 ± 53.29	0.092
8.	HbA1c (%)		5.235.23 ± 0.47	5.295.23 ± 0.33	0.579
9.	No. of organ involvement		3.33 ± 1.12	3.38 ± 1.02	0.887
10.	Type of organ involvement	Respiratory	49 (74.2%)	9 (56.2%)	0.156
		Hepatic	25 (37.8%)	6 (37.5%)	0.978
		Nervous	35 (53%)	8 (50%)	0.828
		Hematological	26 (39%)	7 (43%)	0.750
		Hemodynamic	48 (72%)	12 (75%)	0.854
		Renal	27 (60%)	12 (75%)	0.239
11.	Noradrenaline requirement (mL)		223.13 ± 245.09	387.81 ± 328.13	0.075
12.	Vasopressin requirement (mL)		22.66 ± 33.47	41.36 ± 44.103	0.128
13.	Mechanical ventilation days		9.56 ± 9.84	9.19 ± 8.53	0.880
14.	ICU length of stay (days)		11.98 ± 11.53	9.94 ± 9.27	0.458
15.	Hospital length of stay (days)		19.39 ± 16.50	12.31 ± 10.40	0.039
16.	28-day mortality		24 (36.4%)	14 (87.5%)	<0.001

Data presented as mean ± standard deviation, number (percentage). APACHE II, acute physiology and chronic health evaluation II; SOFA, sequential organ failure assessment; FIL, fasting insulin levels; FBG, fasting blood glucose; HOMA-IR, homeostatic model assessment of insulin resistance. Noradrenaline: 1 mL = 0.08 mg; Vasopressin: 1 mL = 1 unit. A p <0.05 is considered significant